Unrecognized High Occurrence of Genetically Confirmed Hereditary Carnitine Palmitoyltransferase II Deficiency in an Austrian Family Points to the Ongoing Underdiagnosis of the Disease.

carnitine palmitoyltransferase II deficiency family study mutation pedigree underdiagnosis

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2019
Historique:
received: 05 03 2019
accepted: 06 05 2019
entrez: 14 6 2019
pubmed: 14 6 2019
medline: 14 6 2019
Statut: epublish

Résumé

Adult muscle carnitine palmitoyltransferase (CPT) II deficiency is a rare autosomal recessive disorder of long-chain fatty acid metabolism. It is typically associated with recurrent episodes of exercise-induced rhabdomyolysis and myoglobinuria, in most cases caused by a c.338C > T mutation in the

Identifiants

pubmed: 31191612
doi: 10.3389/fgene.2019.00497
pmc: PMC6540962
doi:

Types de publication

Journal Article

Langues

eng

Pagination

497

Références

Hum Mutat. 1999;13(3):210-20
pubmed: 10090476
Neuromuscul Disord. 2000 Mar;10(3):200-5
pubmed: 10734268
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
J Pediatr. 2002 Nov;141(5):734-6
pubmed: 12410208
Neurology. 2003 Apr 22;60(8):1351-3
pubmed: 12707442
Mol Aspects Med. 2004 Oct-Dec;25(5-6):495-520
pubmed: 15363638
Arch Neurol. 2005 Jan;62(1):37-41
pubmed: 15642848
Mol Genet Metab. 2006 Dec;89(4):323-31
pubmed: 16996287
Eur J Hum Genet. 2007 Mar;15(3):272-8
pubmed: 17213840
J Neurol Sci. 2008 Mar 15;266(1-2):97-103
pubmed: 17936304
J Inherit Metab Dis. 2010 Oct;33(5):469-77
pubmed: 20195903
Clin Genet. 2012 Sep;82(3):232-9
pubmed: 21913903
Wien Klin Wochenschr. 2012 Dec;124(23-24):851-4
pubmed: 23184072
J Neurol Sci. 2014 Mar 15;338(1-2):107-11
pubmed: 24398345
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Int J Mol Sci. 2017 Jan 03;18(1):
pubmed: 28054946
Open Access Maced J Med Sci. 2018 Apr 12;6(4):666-668
pubmed: 29731937
Mol Genet Metab Rep. 2018 Mar 06;15:69-70
pubmed: 29744303
J Clin Neurosci. 2019 Jan;59:32-36
pubmed: 30455135

Auteurs

Christina Zach (C)

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch, Austria.
Medical Central Laboratories, Feldkirch, Austria.

Karl Unterkofler (K)

Breath Research Institute, University of Innsbruck, Dornbirn, Austria.
Vorarlberg University of Applied Sciences, Dornbirn, Austria.

Peter Fraunberger (P)

Medical Central Laboratories, Feldkirch, Austria.
Private University of the Principality of Liechtenstein, Triesen, Liechtenstein.

Heinz Drexel (H)

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch, Austria.
Private University of the Principality of Liechtenstein, Triesen, Liechtenstein.
Division of Angiology, Swiss Cardiovascular Center, University Hospital of Bern, Bern, Switzerland.
Drexel University College of Medicine, Philadelphia, PA, United States.

Axel Muendlein (A)

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch, Austria.

Classifications MeSH